Business Description
Neuroscientific Biopharmaceuticals Ltd
ISIN : AU0000012973
Share Class Description:
ASX:NSB: Ordinary SharesDescription
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year EPS without NRI Growth Rate | 42.6 | |||||
| 3-Year FCF Growth Rate | 18 | |||||
| 3-Year Book Growth Rate | -11.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.74 | |||||
| 9-Day RSI | 53.78 | |||||
| 14-Day RSI | 52.74 | |||||
| 12-1 Month Momentum % | -18.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 29.56 | |||||
| Quick Ratio | 29.56 | |||||
| Cash Ratio | 28.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 20.33 | |||||
| ROA % | 17.51 | |||||
| ROIC % | -1131.62 | |||||
| ROC (Joel Greenblatt) % | 3957.14 | |||||
| ROCE % | 22.2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11 | |||||
| PE Ratio without NRI | 11 | |||||
| PB Ratio | 2.12 | |||||
| Price-to-Tangible-Book | 2.75 | |||||
| EV-to-EBIT | 5.56 | |||||
| EV-to-EBITDA | 5.12 | |||||
| EV-to-FCF | 327.73 | |||||
| Price-to-Graham-Number | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 2.75 | |||||
| Price-to-Net-Cash | 2.75 | |||||
| Earnings Yield (Greenblatt) % | 17.99 | |||||
| FCF Yield % | 0.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neuroscientific Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | 0.005 | ||
| Beta | 1.37 | ||
| Volatility % | 78.28 | ||
| 14-Day RSI | 52.74 | ||
| 14-Day ATR (A$) | 0.004182 | ||
| 20-Day SMA (A$) | 0.05665 | ||
| 12-1 Month Momentum % | -18.92 | ||
| 52-Week Range (A$) | 0.035 - 0.14 | ||
| Shares Outstanding (Mil) | 144.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neuroscientific Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neuroscientific Biopharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neuroscientific Biopharmaceuticals Ltd Frequently Asked Questions
What is Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)'s stock price today?
The current price of ASX:NSB is A$0.06. The 52 week high of ASX:NSB is A$0.14 and 52 week low is A$0.04.
When is next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)?
The next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) is .
Does Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) pay dividends? If so, how much?
Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers